These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 8640855

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A, Ghidina M.
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract] [Full Text] [Related]

  • 3. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J, Niehaus M, Korte T.
    Dtsch Med Wochenschr; 2002 Oct 11; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract] [Full Text] [Related]

  • 4. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R, Cinca J, Marber M.
    Eur Heart J; 1999 Mar 11; 20(6):397-8. PubMed ID: 10213339
    [No Abstract] [Full Text] [Related]

  • 5. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.
    Eur Heart J; 2000 Dec 11; 21(24):2071-8. PubMed ID: 11102258
    [Abstract] [Full Text] [Related]

  • 6. The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death.
    Talajic M, Mitchell LB, Hadjis T.
    Can J Cardiol; 2000 Jun 11; 16 Suppl C():26C-8C. PubMed ID: 10887275
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Implantable cardioverter-defibrillator: present and future indications.
    Block M, Scheld H, Breithardt G.
    Arch Mal Coeur Vaiss; 1996 Feb 11; 89 Spec No 1():141-7. PubMed ID: 8734176
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    Circulation; 2006 Feb 14; 113(6):776-82. PubMed ID: 16461817
    [Abstract] [Full Text] [Related]

  • 12. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK, Mehta D, Gomes JA.
    Mt Sinai J Med; 2005 Jan 14; 72(1):1-9. PubMed ID: 15682255
    [Abstract] [Full Text] [Related]

  • 13. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH, Yee R, Jung W.
    J Am Coll Cardiol; 1996 Aug 14; 28(2):400-10. PubMed ID: 8800117
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of ventricular arrhythmias].
    Bytesník J.
    Vnitr Lek; 2003 Sep 14; 49(9):754-62. PubMed ID: 14584428
    [Abstract] [Full Text] [Related]

  • 15. [Implantable cardioverter-defibrillators in the prevention of sudden cardiac death].
    Kozák M, Krivan L, Semrád B.
    Vnitr Lek; 2001 Jun 14; 47(6):361-70. PubMed ID: 11494881
    [Abstract] [Full Text] [Related]

  • 16. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D.
    Europace; 2009 Mar 14; 11(3):289-96. PubMed ID: 19095687
    [Abstract] [Full Text] [Related]

  • 17. The utilization of the implantable defibrillator--a European enigma.
    Camm AJ, Nisam S.
    Eur Heart J; 2000 Dec 14; 21(24):1998-2004. PubMed ID: 11102250
    [No Abstract] [Full Text] [Related]

  • 18. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
    Tung R, Swerdlow CD.
    Circulation; 2009 Sep 08; 120(10):825-7. PubMed ID: 19704090
    [No Abstract] [Full Text] [Related]

  • 19. Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis.
    Bernardo P, Conforti ML, Bellando-Randone S, Pieragnoli P, Blagojevic J, Kaloudi O, Guiducci S, Porta F, Padeletti L, Gensini GF, Matucci-Cerinic M.
    J Rheumatol; 2011 Aug 08; 38(8):1617-21. PubMed ID: 21632680
    [Abstract] [Full Text] [Related]

  • 20. Secondary prevention of sudden cardiac death in coronary artery spasm: is implantable cardioverter defibrillator always efficient?
    Letsas KP, Filippatos GS, Efremidis M, Sideris A, Kardaras F.
    Int J Cardiol; 2007 Apr 12; 117(1):141-3. PubMed ID: 17046086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.